Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 1 Trial

Recent news which mentions Phase 1 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
Breaking Down Molly: Swiss University Studies How MDMA's Components Might Affect Humans
Tickers MDMA MNMD
Tags Psychedelics MNMD Dr/ Matthias Liechti
From Benzinga
Codiak BioSciences' Engineered Exosome Candidates Show Early Antitumor Activity
Tickers CDAK
Tags Health Care Biotech Phase 1 Trial
From Benzinga
eFFECTOR's Cancer Therapy Achieves Two Partial Responses In Early-Stage Study
Tickers EFTR
Tags Benzinga Penny Stocks EFTR
From Benzinga
Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients
Tickers BNTX MRK RHHBF RHHBY
Tags Pancreatic Cancer RHHBY General
From Benzinga
Keros Therapeutics Posts Preliminary Data Early-Stage KER-012 Trial
Tickers KROS
Tags Health Care General Phase 1 Trial
From Benzinga
Caribou's Lymphoma Candidate Shows 100% Response Rate In Early-Stage Study
Tickers CRBU
Tags General why it's moving News
From Benzinga
FDA Gives Green Signal To Human Trial For Sorrento's STI-9167 Against Omicron
Tickers SRNE
Tags Trading Ideas Penny Stocks FDA
From Benzinga
Sanofi's Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine
Tickers SNY
Tags News Briefs SNY
From Benzinga
AbbVie - Genmab Post Epcoritamab Data From Early-Stage Blood Cancer Study
Tickers ABBV GMAB
Tags GMAB News Phase 1 Trial
From Benzinga
Cocrystal Pharma Posts Favorable Preliminary Data From Influenza A Antiviral Candidate Trial
Tickers COCP
Tags Health Care Biotech Phase 1 Trial
From Benzinga
Repare Therapeutics Shares Dip After Updated RP-3500 Data In Solid Tumors
Tickers RPTX
Tags General Movers why it's moving
From Benzinga
FDA Approves BioCardia's Phase 1 Trial With Cell Therapy In COVID-19, Shares Jump
Tickers BCDA
Tags Market News Trading Ideas Penny Stocks
From Benzinga
IO Biotech Reveals Updated Data From IO102-IO103/Opdivo Combo Trial In Melanoma
Tickers BMY IOBT
Tags Benzinga Market News Phase 2 Trial
From Benzinga
BioNTech Posts Interim Phase 1 Data From CAR-T/Cancer Vaccine Combo In Solid Tumors
Tickers BNTX
Tags BNTX General Health Care
From Benzinga
AIM ImmunoTech Shares Jump On Positive Data From Ampligen Study In Breast Cancer Setting
Tickers AIM
Tags breast cancer Movers why it's moving
From Benzinga
Zentalis Pharma Posts Initial Clinical Data On Its Wee1 Inhibitor In Ovarian Cancer
Tickers ZNTL
Tags Health Care Phase 1 Trial Small Cap
From Benzinga
VYNE Therapeutics Shares Gain After Positive Atopic Dermatitis Trial Of FMX114
Tickers VYNE
Tags atopic dermatitis Phase 1 Trial Biotech
From Benzinga
Seres Therapeutics Ditches Its SER-301 Phase 1b Second Study In Ulcerative Colitis
Tickers MCRB
Tags MCRB General News
From Benzinga
VBI Vaccines To Start Clinical Study Of Pan-Coronavirus Vaccine Candidate This Year
Tickers VBIV
Tags Phase 1 Trial Biotech Small Cap
From Benzinga
Stealth Bio's SBT-272 Shows Encouraging Action In Huntington's Disease Animal Model
Tickers MITO
Tags General MITO Briefs
From Benzinga
Portage Biotech Shares Encouraging Preliminary Safety Data From Lead iNKT Agonists Program In Cancer Patients
Tickers BMY MRK PRTG
Tags Benzinga Market News MRK
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
Tickers LGVN
Tags Exclusives News General
From Benzinga
CureVac - GSK Start Dosing In Next-Gen COVID-19 Vaccine Candidate Trial
Tickers CVAC GSK
Tags Benzinga Market News Health Care
From Benzinga
Synthetic Biologics' VCN-01 Shows Favorable Safety Profile, Clinical Activity In Early-Stage Cancer Study
Tickers SYN
Tags Health Care General News
From Benzinga
Ionis-Biogen Partnered Amyotrophic Lateral Sclerosis Trial Disappoints
Tickers BIIB IONS
Tags Health Care BIIB Biotech
From Benzinga
Pluristem's PLX-R18 Shows Meaningful Advantage Over Other Treatments In Transplant Patients
Tickers PSTI
Tags Market News Penny Stocks Benzinga
From Benzinga
Aligos Pulls Plug On Early-Stage Chronic Hepatitis B Treatment Candidate
Tickers ALGS
Tags General Health Care ALGS
From Benzinga
Why ORIC Pharmaceuticals Shares Are Plunging Today
Tickers ORIC
Tags Market News Benzinga Trading Ideas
From Benzinga
Terns Reports Topline Results from Early-Stage NASH Study
Tickers TERN
Tags Market News Trading Ideas Penny Stocks
From Benzinga
Pulmatrix's COPD Candidate Shows Early Safety, Preliminary Pharmacokinetic Results
Tickers PULM
Tags Trading Ideas Benzinga Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.